Aspirin’s Forgotten Anticancer Function
Reviewed by Keith W. Vrbicky, Sr., MD
Analysis by Dr. Joseph Mercola
September 19, 2024
STORY AT-A-GLANCE
- Aspirin, traditionally used for pain relief, shows promising anticancer properties. Recent research highlights its potential in cancer prevention and treatment, with a more potent analog, 2,6-dihydroxybenzoic acid, showing even greater promise
- Combining aspirin with vitamin C demonstrates superior results in shrinking tumors and extending survival times compared to either compound alone or conventional chemotherapy drugs, while being gentler on healthy cells
- Long-term, low-dose aspirin use (75 mg+ daily for several years) can significantly reduce colorectal cancer incidence and mortality, with benefits most pronounced for proximal colon cancers and after 20+ years of use
- Aspirin’s cancer-fighting potential extends beyond colorectal cancer, showing promise in reducing risks for esophageal, stomach, lung, prostate and breast cancers, with overall cancer incidence potentially reduced by 20% to 30% after three to five years of use
- For maximum benefit, choose immediate-release aspirin without additives. Optimal dosage ranges from 82 mg to 325 mg daily, taken with meals. Genetic testing may help personalize aspirin use for cancer prevention in the future